相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Daniel R. Richardson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway
Takeshi Fujino et al.
NATURE COMMUNICATIONS (2021)
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy
Raphael Itzykson et al.
BLOOD (2021)
Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
Sally B. Killick et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations
Lili Zhou et al.
HEMATOLOGY (2021)
Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes
Lingxu Jiang et al.
CANCER SCIENCE (2020)
Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations
Yun Lin et al.
HEMATOLOGY (2020)
The role of ASXL1 in hematopoiesis and myeloid malignancies
Shuhei Asada et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine
John N. Allan et al.
LEUKEMIA & LYMPHOMA (2018)
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
Abhishek A. Mangaonkar et al.
LEUKEMIA RESEARCH (2018)
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2018)
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
Po-Han Lin et al.
CANCER MEDICINE (2017)
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes
Lingyun Wu et al.
TUMOR BIOLOGY (2016)
Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis
Yun Lin et al.
HEMATOLOGY (2016)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features
V. I. Gaidzik et al.
LEUKEMIA (2016)
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
Chi-Yuan Yao et al.
ONCOTARGET (2016)
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
Lene Sofie Granfeldt Ostgard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia
Velizar Shivarov et al.
LEUKEMIA & LYMPHOMA (2015)
Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia
Yajuan Cui et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2015)
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice
Jiapeng Wang et al.
BLOOD (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
Aline Renneville et al.
ONCOTARGET (2014)
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann et al.
BLOOD (2012)
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Klaus H. Metzeler et al.
BLOOD (2011)
Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
Felicitas Thol et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Therapeutic Advances in Acute Myeloid Leukemia
Alan Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Wen-Chien Chou et al.
BLOOD (2010)
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
分享论文
